Huma Therapeutics Launches Huma Intelligence Scribe Powered by NVIDIA

New York, Jan 2026 — Huma Therapeutics today announced the development of Huma Intelligence Scribe, an AI-powered solution designed to transform the way clinical consultations are documented and understood. Leveraging NVIDIA technology (e.g., NVIDIA Parakeet ASR, part of the NVIDIA Nemotron Speech open model collection, and NVIDIA Titanet, and Llama Nemotron embedding and reranking models, part of the Nemotron RAG model collection), Huma Intelligence Scribe transcribes consultations in real time and generates actionable insights for both patients and healthcare providers.

The solution produces two tailored summaries for each consultation:

● Patient Summary: Simplifies medical terminology into language that is easy for patients to understand, supporting better comprehension and engagement.

● Clinician Summary: Highlights key clinical points and suggests additional questions that can be asked to ensure a thorough evaluation, enhancing decision-making and efficiency.

“Huma Intelligence Scribe is designed to streamline clinical workflows and improve communication between patients and healthcare providers,” said Dan Vahdat CEO & Founder at Huma Therapeutics.“. By building on NVIDIA Nemotron, we are leveraging advanced AI technology to provide accurate real-time transcription and intelligent insights that support both patients and clinicians during consultations.”

Huma Intelligence Scribe is expected to begin pilot testing with select clinical partners in Q1 2026.